Cellular response of human pulmonary endothelial cells to linoleic acid and its epoxide derivatives Source: Eur Respir J 2001; 18: Suppl. 33, 406s Year: 2001
Free fatty acid receptors, FFAR1 and FFAR4, are novel bronchodilator targets in mouse and human precision-cut lung slices Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Differential actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA in macrophages and bronchial epithelial cells Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013
Anti-inflammatory and cytoprotective actions of the endogenous docosahexaenoic acid (DHA) electrophilic derivative 17-oxo-DHA Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Unbound pharmacologically active metabolite des-CIC is not detectable in human skeletal muscle and subcutaneous adipose tissue after inhalation of high-dose ciclesonide Source: Eur Respir J 2006; 28: Suppl. 50, 666s Year: 2006
Esterases involved in the hydrolysis of ciclesonide in human tissues Source: Eur Respir J 2003; 22: Suppl. 45, 267s Year: 2003
Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy Source: Eur Respir J, 50 (3) 1700782; 10.1183/13993003.00782-2017 Year: 2017
Capillary-alveolar macromolecular permeability in oleic acid lung injury is not reduced by terbutaline Source: Eur Respir J 2002; 20: Suppl. 38, 36s Year: 2002
Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002
Effect of intermittent hypoxia on the expression of fatty acid binding proteins in human adipocytes and macrophages Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors in lipopolysaccharide-induced airway inflammation and tracheal hyperreactivity in mice Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Late-breaking abstract: Cycloxygenase- and lypoxigenase-dependent generation of omega-3 electrophilic fatty acid-derivatives with anti-inflammatory properties Source: Annual Congress 2011 - Lung cell biology Year: 2011
Tissue retention and esterification is greater for budesonide than for ciclesonide in trachea ex vivo Source: Eur Respir J 2004; 24: Suppl. 48, 345s Year: 2004
Evidence of in vivo esterification of budesonide in humans Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005
Esterification prolongs retention of budesonide but not ciclesonide - active principle in rat trachea Source: Eur Respir J 2005; 26: Suppl. 49, 369s Year: 2005
Short-chain fatty acids are potent modulators of allergic airway inflammation Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
The uptake of ciclesonide-active metabolite and budesonide into human hepatocytes in vitro – the effect of serum protein binding Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Pulmonary targeting of ciclesonide and its active metabolite as determined in an ex-vivo rat receptor-binding assay Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Budesonide is retained in the airways longer than mometasone furoate due to the reversible formation of lipophilic budesonide fatty acid esters - significance for asthma therapy Source: Eur Respir J 2002; 20: Suppl. 38, 53s Year: 2002